|
Tech group briefly becomes China's most valuable listed company in mainland's biggest IPO since 2010
|
|
CXMT closed its first day of trading with a market capitalization of $85 billion
|
|
No strikes have been reported from either side since Friday, leaving oil investors optimistic about a resolution to the conflict.
|
|
TransDigm Group has announced it has entered into a definitive agreement to acquire Prince & Izant a portfolio company of Industrial Growth Partners, for approximately $1.066 billion in cash, including certain tax benefits. Headquartered in Cleveland, Ohio, Prince & Izant is a leading global designer and manufacturer of highly engineered brazing alloys and specialty metal […]
The post Deal Roundup: TransDigm enters deal to snap up Prince & Izant, Cinven and La Caisse to acquire Optio appeared first on AltAssets Private Equity News.
|
|
TODAY Derek From is a successful lawyer in Canada. Twelve years ago, he was roughing it in Arizona, trying to break into the recording industry. So he started selling his blood plasma. Twice a week, he sat for an hour in a Grifols Biomat centre, as an apheresis machine whirled, siphoning the plasma out of his blood. For this, he took home $45. "As a poor person" at the time, he found that "a huge economic benefit".
It was also part of a thriving industry. Blood products made up a remarkable 1.6% of American exports in 2016. Since 2005 blood-plasma collections have nearly quadrupled. To critics, this is evidence of a rapacious industry coercing the poor to auction bits of themselves to make ends meet. In fact, plasma, 90% of which is water, is quickly replenished. Giving it has no obvious negative health effects—though the long-term consequences of repeated siphoning have not been fully studied. Strict testing (and later heat-treating) of the extracted plasma ensures that those with communicable...Continue reading
|
|
